Loading company…
Riskpilot
← Back to search
Sign in
Get full access
ENT & PED AB
AB
Active
Org 5590983945
Other financial service activities, except insurance and pension funding n.e.c. · NACE 6499
Est. 2017
0 employees
Watchlist
Share
Overview
Financials
People & ownership
Related companies
Revenue 2025
SEK 270K
-27% vs 2024
EBITDA margin
65.6%
+57% vs 2024
Equity ratio
77.0%
Financial strength
Net profit 2025
SEK 141K
+56% vs 2024
EBITDA — year on year
SEK millions
0M
-0M
-1M
-1M
-1M
0M
2021
0M
0%
2022
0M
0%
2023
0M
0%
2024
0M
0%
2025
Key figures
Annual report 2025
Revenue
SEK 270K
-27%
EBITDA
SEK 177K
+57%
Net profit
SEK 141K
+56%
Total assets
SEK 391K
+49%
Equity
SEK 301K
+88%
Employees
0
—
Company information
Legal name
ENT & PED AB
Org number
5590983945
Legal form
Aktiebolag
NACE code
6499 · Other financial service activities, except insurance and pension funding n.e.c.
Founded
25 januari 2017
Share capital
SEK 50 000
Employees
0
VAT registered
No
Audit selected
No
Last report
2025-12-31
Financial year
January – December
Signatory rights
Firman tecknas av styrelsen Firman tecknas ensam av externa firmatecknaren
Company purpose
Sjukvård. Konsultation inom vård och vårdutbildning. Kapitalförvaltning.
Contact
Address
Email
entpedab@gmail.com
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
Visit risika.com
Explore
Companies in Other financial service activities, except insurance and pension funding n.e.c.
Companies in Örebro
All Sweden companies
Revenue
SEK millions
0M
0M
1M
1M
1M
1M
2021
0M
2022
1M
2023
0M
2024
0M
2025
EBITDA
SEK millions
0M
0M
1M
1M
1M
0M
2021
0M
2022
0M
2023
0M
2024
0M
2025
Income statement
SEK thousands
Item
2021
2022
2023
2024
2025
Revenue
588
256
552
367
270
Staff expenses
—
21
60
−13
−9
EBITDA
400
96
403
113
177
Depreciation & amort.
−0
—
−22
—
—
EBIT
400
96
381
113
177
Net financials
—
0
134
1
1
Profit before tax
400
96
515
114
178
Tax
−82
−20
−78
−23
−36
Net profit
318
76
437
90
141
Balance sheet
SEK thousands
Item
2021
2022
2023
2024
2025
Total assets
1 151
1 137
634
263
391
Equity
959
1 036
487
160
301
Long-term debt
0
—
—
—
—
Short-term debt
192
101
147
103
90
Total debt
192
101
147
103
90
Financial ratios
5-year trend
EBITDA margin
65.6%
This company
15.8%
Market median
+315% vs market
2021
2025
Equity ratio
77.0%
This company
38.2%
Market median
+102% vs market
2021
2025
Return on equity
46.9%
This company
18.4%
Market median
+155% vs market
2021
2025
Net profit margin
52.3%
This company
8.1%
Market median
+546% vs market
2021
2025
Asset turnover
0.69×
This company
1.12×
Market median
-38% vs market
2021
2025
Debt / equity
0.30×
This company
0.62×
Market median
+52% vs market
2021
2025
Annual reports & filings
Annual report 2025
Filed via Bolagsverket / SCB · Period 2025-01-01 – 2025-12-31
View
PDF
Annual report 2024
Filed via Bolagsverket / SCB · Period 2024-01-01 – 2024-12-31
View
PDF
Annual report 2023
Filed via Bolagsverket / SCB · Period 2023-01-01 – 2023-12-31
View
PDF
Annual report 2022
Filed via Bolagsverket / SCB · Period 2022-01-01 – 2022-12-31
View
PDF
Annual report 2021
Filed via Bolagsverket / SCB · Period 2021-01-01 – 2021-12-31
View
PDF
Management
Actively employed in the business
Name
Role
Member since
Current (1)
JS
Jan Sidney Johannes Larsson
External Signatory
External Signatory
2024
Board of directors
Non-executive oversight
Name
Role
Member since
Current (2)
VN
Vasiliki Niki Mitselou
Deputy Board Member
2022
EN
Eleftherios Ntouniadakis
Board of Directors
2022
Shareholders
As of last annual report
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive.
Learn more
.
Company hierarchy
No registered parent or subsidiaries
Board network connections
Board members of ENT & PED AB also hold positions in
0
other companies.
Person
Role here
Other companies
Jan Sidney Johannes Larsson
External Signatory
0 companies
Vasiliki Niki Mitselou
Deputy Board Member
0 companies
Eleftherios Ntouniadakis
Board of Directors
0 companies